| Daniel Thomas Murphy, PHD | |
|
18th Medical Group, Bidg 626, Unit 5142, Apo, AP 96368-5142 | |
| (315) 630-4780 | |
| Not Available |
| Full Name | Daniel Thomas Murphy |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 18th Medical Group, Bidg 626, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528057049 | NPI | - | NPPES |
| 200503220 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 20041773A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Thomas Murphy, PHD Psc 80, Box 20479, Apo, AP 96367-9998 Ph: (317) 863-0775 | Daniel Thomas Murphy, PHD 18th Medical Group, Bidg 626, Unit 5142, Apo, AP 96368-5142 Ph: (315) 630-4780 |
News Archive
A greater frequency of severe sepsis among black patients is attributable to higher rates of infection and higher risks of organ dysfunction than what white patients experience, according to a study in the June 23/30 issue of JAMA.
Five years after Wal-Mart Stores Inc. promised to open thousands of health-care clinics in its sprawling supercenters, it has fallen far behind its industry rivals in what has become a race to provide basic medical care in stores.
The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference taking place in Vienna, Austria said today. And, with millions of lives dependent on expanding access to antiretroviral treatment to all those clinically in need, researchers and clinicians are partnering in new ways to find the most effective and efficient methods to deliver treatment and strengthen health systems.
New performance measures have been developed for patients on warfarin that may save lives and money.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.
› Verified 2 days ago
Timothy Burnett, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Brian D. Allgood Army Community Hospital (bdaach), Unit 15245, Apo, AP 96271 Phone: 630-408-4502 | |
Dr. Joshua R Staples, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 765-398-5139 | |
Dr. Ihan Lam, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 549 Hc/bdaach, Unit 15245, Apo, AP 96271 Phone: 315-737-5963 | |
Mayra A. Rodriguez Figueroa, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Unit 2022, Apo, AP 96264 Phone: 315-782-7133 | |
Dr. Josilyn Camille Law, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 374 Mdg, Unit 5071, Apo, AP 96328 Phone: 315-255-3566 | |
Dr. Arthur Lloyd Miller, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2504 S. Chicago, 336 Trss/sgf Usaf Sere School, Apo, AP 99011 Phone: 509-240-3899 Fax: 509-247-3543 | |
Dr. Laura Johnson, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 35 Mdg, Unit 5024, Apo, AP 96319 Phone: 315-226-3230 |